Viewing Study NCT02512692


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT02512692
Status: TERMINATED
Last Update Posted: 2024-11-18
First Post: 2015-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Medical University of South Carolina
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 102254
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators